Structure and function of telomerase

Current Opinion in Cell Biology

Volumn 8, Issue 3, 1996, Pages 374-380

  Collins, Kathleen ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DNA; DNA BINDING PROTEIN; DNA POLYMERASE; RIBONUCLEOPROTEIN; RNA; TELOMERASE;

DNA STRUCTURE; DNA SYNTHESIS; ENZYME ACTIVITY; ENZYME ASSAY; ENZYME REGULATION; ENZYME STRUCTURE; ENZYME SUBSTRATE COMPLEX; PRIORITY JOURNAL; PROTEIN DNA INTERACTION; SHORT SURVEY; TANDEM REPEAT; TELOMERE; TETRAHYMENA;

EUKARYOTA; TETRAHYMENA;

EID: 0029938746     PISSN: 09550674     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0955-0674(96)80013-5     Document Type: Article

References (59)

1. Greider CW, Blackburn EH: The telomere terminal transferase of Tetrahymena is a ribonucleoprotein enzyme with two kinds of primer specificity. Cell 1987, 51:887-898.
2. Greider CW, Blackburn EH: Identification of a specific telomere terminal transferase activity in Tetrahymena extracts. Cell 1985, 43:405-413.
3. Blackburn EH, Greider CW: Telomeres. Plainview, New York: Cold Spring Harbor Laboratory Press; 1995.
4. Blackburn EH: Telomerase. In The RNA World. Edited by Gestland RF, Atkins JF. Plainview, New York: Cold Spring Harbor Laboratory Press; 1993:557-576.
5. Greider CW: Mammalian telomere dynamics: healing, fragmentation, shortening and stabilization. Curr Opin Genet Dev 1994, 4:203-211.
6. Harley CB, Kim NW, Prowse KR, Weinrich SL, Hirsch KS, West MD, Bacchetti S, Hirte HW, Counter CM, Greider CW et al.: Telomerase, cell immortality, and cancer. Cold Spring Harb Symp Quant Biol 1994, 59:307-315.
7. Zakian VA: Telomeres: beginning to understand the end. Science 1995, 270:1601-1607.
8. Cohn M, Blackburn EH: Telomerase in yeast. Science 1995, 269:396-400. This paper describes the most convincing in vitro assay for S. cerevisiae telomerase. Fractionated whole cell extracts were examined for RNase-sensitive, primer sequence dependent incorporation of dGTP and TTP. Nucleotides were added in register with the 3′ end of sequence-permuted telomeric primers, and ddNTPs were incorporated at predicted positions in the product DNA. Product DNA synthesis required the telomerase RNA but was indistinguishable in the presence or absence of EST1 p, a gene product required for telomere maintenance [23]. Hence EST1 probably does not encode the catalytic subunit of telomerase.
9. Lin J, Zakian VA: An in vitro assay for Saccharomyces telomerase requires EST1. Cell 1995, 81:1127-1135.
10. Lue NF, Wang JC: ATP-dependent processivity of a telomerase activity from Saccharomyces cerevisiae. J Biol Chem 1995, 270:21453-21456.
11. Hanish JP, Yanowitz JL, De Lange T: Stringent sequence requirements for the formation of human telomeres. Proc Natl Acad Sci USA 1994, 91:8861-8865.
12. Zhong Z, Shiue L, Kaplan S, De Lange T: A mammalian factor that binds telomeric TTAGGG repeats in vitro. Mol Cell Biol 1992, 12:4834-4843.
13. Chong L, Van Steensel B, Broccoli D, Erdjument-Bromage H, Hanish J, Tempst P, De Lange T: A human telomeric protein. Science 1995, 270:1663-1667. This paper describes the purification and cloning of the gene encoding a human protein that specifically binds to double-stranded telomeric repeats. The protein, human telomeric repeat binding factor, is shown to localize to telomeres in vivo, and represents the first vertebrate telomeric repeat binding protein whose encoding gene has been cloned.
14. Shippen DE, Blackburn EH, Price CM: DNA bound by the Oxytricha telomere protein Is accessible to telomerase and other DNA polymerases. Proc Natl Acad Sci USA 1994, 91:405-409.
15. Greider CW, Blackburn EH: A telomeric sequence in the RNA of Tetrahymena telomerase required for telomere repeat synthesis. Nature 1989, 337:331-337.
16. Shippen-Lentz D, Blackburn EH: Functional evidence for an RNA template in telomerase. Science 1990, 247:546-552.
17. Romero DP, Blackburn EH: A conserved secondary structure for telomerase RNA. Cell 1991, 67:343-353.
18. Melek M, Davis BT, Shippen DE: Oligonucleotides complementary to the Oxytricha nova telomerase RNA delineate the template domain and uncover a novel mode of primer utilization. Mol Cell Biol 1994, 14:7827-7838.
19. Lingner J, Hendrick LL, Cech TR: Telomerase RNAs of different ciliates have a common secondary structure and a permuted template. Genes Dev 1994, 8:1984-1998.
20. McCormick-Graham M, Romero DP: Ciliate telomerase RNA structural features. Nucleic Acids Res 1995, 23:1091-1097.
21. Singer MS, Gottschling DE: TLC1: template RNA component of Saccharomyces cerevisiae telomerase. Science 1994, 266:404-409. After much hunting for telomerase components in S. cerevisiae, the first sighting is described in this paper. Partial telomerase RNA clones were identified as high-copy suppressors of silencing. Genetic disruption of the RNA resulted in telomere shortening and in senescence; mutations of the RNA template region were copied into telomeric DNA in vivo.
22. Kramer KM, Haber JE: New telomeres in yeast are initiated with a highly selected subset of TG1-3 repeats. Genes Dev 1993, 7:2345-2356.
23. Lundblad V, Szostak JW: A mutant with a defect in telomere elongation leads to senescence in yeast. Cell 1989, 57:633-643.
24. McEachem MJ, Blackburn EH: Runaway telomere elongation caused by telomerase RNA gene mutations. Nature 1995, 376:403-409. The K. lactis telomerase RNA was cloned by exploiting the long telomeric repeats found in this organism. Genetic disruption of the RNA caused senescence, and mutations of the RNA in the template region resulted in mutant telomeric repeat synthesis, loss of telomere-length regulation, and loss of viability. The use of telomerases with altered specificity, in combination with other techniques, will continue to provide insights into mechanisms for telomere-length regulation.
25. Lundblad V, Blackburn EH: An alternative pathway for yeast telomere maintenance rescues est1-senescence. Cell 1993, 73:347-360.
26. Feng J, Funk WD, Wang S, Weinrich SL, Avilion AA, Chiu C, Adams RR, Chang E, Allsopp RC, Yu J et al.: The RNA component of human telomerase. Science 1995, 269:1236-1241. The human telomerase RNA was cloned and expression of the RNA was examined in cells and tissues. Many or all cells and tissues appear to contain telomerase RNA, but with up to 10-fold differences in levels. Antisense RNA expression caused crisis in some cultures, although significant telomere length and telomerase activity were maintained.
27. Blasco MA, Funk W, Villeponteau B, Greider CW: Functional characterization and developmental regulation of mouse telomerase RNA. Science 1995, 269:1267-1270. The mouse telomerase RNA was cloned and expression of the RNA examined in cells and tissues. Like the human RNA, many or all mouse cells and tissues appear to contain telomerase RNA, with up to 10-fold differences in the levels found. In several tissues, RNA levels decreased during development.
28. Yu G, Bradley JD, Attardi LD, Blackburn EH: In vivo alteration of telomere sequences and senescence caused by mutated Tetrahymena telomerase RNAs. Nature 1990, 344:126-132.
29. Yu G, Blackburn EH: Developmentally programmed healing of chromosomes by telomerase in Tetrahymena. Cell 1991, 67:823-832.
30. Autexier C, Greider CW: Functional reconstitution of wildtype and mutant Tetrahymena telomerase. Genes Dev 1994, 8:563-575.
31. Autexier C, Greider CW: Boundary elements of the Tetrahymena telomerase RNA template and alignment domains. Genes Dev 1995, 9:2227-2239. Mutant telomerase RNAs were combined with wild-type proteins in vitro to assay the effect of template region changes on telomerase activity. Alteration of the template had complex effects. A region 5′ of the template sequence helped to define template boundaries.
32. •].
33. Gilley D, Blackburn EH: Specific RNA residue interactions required for enzymatic functions of Tetrahymena telomerase. Mol Cell Biol 1996, 16:66-75. See annotation [32•].
34. Zaug AJ, Cech TR: Analysis of the structure of Tetrahymena nuclear RNAs in vivo: telomerase RNA, the self-splicing rRNA intron, and U2 snRNA. RNA 1995, 1:363-374.
35. Bhattacharyya A, Blackburn EH: Architecture of telomerase RNA. EMBO J 1994, 13:5721-5731.
36. Fang G, Cech TR: Telomerase RNA localized in the replication band and spherical subnuclear organelles in hypotrichous ciliates. J Cell Biol 1995, 130:243-253.
37. Collins K, Kobayashi R, Greider CW: Purification of Tetrahymena telomerase and cloning of genes encoding the two protein components of the enzyme. Cell 1995, 81:677-686. This paper represents the first identification of protein components of telomerase in any species. Tetrahymena telomerase was purified and shown to contain two proteins in addition to the 159 nucleotide teiomerase RNA. Nucleic acid binding properties of the proteins were examined. Genes encoding the proteins were cloned using peptide sequence information and the genes were shown to encode novel proteins.
38. Collins K, Greider CW: Utilization of ribonucleotides and RNA primers by Tetrahymena telomerase. EMBO J 1995, 14:5422-5432. Ribonucleotides and RNA primers were shown to serve as substrates for telomerase. Substitution of RNA at different positions in a primer had different consequences, suggesting that there are multiple distinct sites of enzyme-primer interaction.
39. Joyce GF, Orgel LE: Prospects for understanding the origin of the RNA world. In The RNA World. Edited by Gesteland RF, Atkins JF. Flainview, New York: Cold Spring Harbor Laboratory Press; 1993:1-25.
40. Kohlstaedt LA, Wang J, Freidman JM, Rice PA, Steitz TA: Crystal structure at 3.5 Ȧ resolution of HIV-1 reverse transcriptase complexed with an inhibitor. Science 1992, 256:1783-1790.
41. Collins K, Greider CW: Nucleolytic cleavage and non-processive elongation catalyzed by Tetrahymena telomerase. Genes Dev 1993, 7:1364-1376.
42. Lee MS, Blackburn EH: Sequence-specific DNA primer effects on telomerase polymerization activity. Mol Cell Biol 1993, 13:6586-6599.
43. Chamberlin MJ: New models for the mechanism of transcription elongation and its regulation. In The Harvey Lectures. Wiley-Liss; 1993:1-21.
44. Kim NW, Piatyszek MA, Prowse KR, Harley CB, West MD, Ho PLC, Coviello GM, Wright WE, Weinrich SL, Shay JW: Specific association of human telomerase activity with immortal cells and cancer. Science 1994, 266:2011-2014. A telomerase assay with increased sensitivity was developed (using the polymerase chain reaction to amplify telomerase product DNA) and employed to assay telomerase activity in a variety of human cells, tissues, and cancers. Most immortal cell lines and cancers showed higher telomerase activity than did primary cells or normal tissue.
45. Hiyama E, Hiyama K, Yokoyama T, Matsuura Y, Piatyszek MA, Shay JW: Correlating telomerase activity levels with human neuroblastoma outcomes. Nat Med 1995, 1:249-255.
46. Murnane JP, Sabatier L, Marder BA, Morgan WF: Telomere dynamics in an immortal cell line. EMBO J 1994, 13:4953-4962.
47. Bryan TM, Englezou A, Gupta J, Bacchetti S, Reddel RR: Telomere elongation in immortal human cells without detectable telomerase activity. EMBO J 1995, 14:4240-4248. Telomere length and telomerase activity were assayed in a number of immortalized human cell lines. Not all cell lines possessed active telomerase, but all immortalized cell lines that lacked telomerase had telomeres which were longer and more heterogeneous than in telomerase-positive cell lines. In combination with other results, these findings suggest that a non-telomerase-dependent mechanism for telomere elongation is likely to exist, characterized by more variable telomere length.
48. Rogan EM, Bryan TM, Hukku B, MacLean K, Chang AC, Moy EL, Englezou A, Warnford SG, Dalla-Pozza L, Reddel RR: Alterations in p53 and p16INK4 expression and telomere length during spontaneous immortalization of Li-Fraumeni syndrome fibroblasts. Mol Cell Biol 1995, 15:4745-4753.
49. Counter CM, Gupta J, Harley CB, Leber B, Bacchetti S: Telomerase activity in normal leukocytes and in hematologic malignancies. Blood 1995, 85:2315-2320. Telomerase activity was detected in leukocytes, with some differences in activity level between normal and malignant cells.
50. Broccoli D, Young JW, De Lange T: Telomerase activity in normal and malignant hematopoietic cells. Proc Natl Acad Sci USA 1995, 92:9082-9086. Telomerase activity was detected in a variety of normal human blood cell populations and at similar levels in hematologic malignancies.
51. Hiyama K, Hirai Y, Kyoizumi S, Akiyama M, Hiyama E, Piatyszek MA, Shay JW, Ishioka S, Yamakido M: Activation of telomerase in human lymphocytes and hematopoietic progenitor cells. J Immunol 1995, 155:3711-3715. Telomerase activity was detected in normal human blood cells and was shown to increase with mitogenic stimulation of cells in vitro.
52. Vaziri H, Dragowska W, Allsopp RC, Thomas TE, Harley CB, Lansdorp PM: Evidence for a mitotic clock in human hematopoietic stem cells: loss of telomeric DNA with age. Proc Natl Acad Sci USA 1994, 91:9857-9860. Telomeres in a stem cell population from human blood were shown to be eroded with cell proliferation, raising the possibility that the proliferative lifespan of these cells is limited.
53. Prowse KR, Greider CW: Developmental and tissue-specific regulation of mouse telomerase and telomere length. Proc Natl Acad Sci USA 1995, 92:4818-4822.
54. Chadeneau C, Siegel P, Harley CB, Muller WJ, Bacchetti S: Telomerase activity in normal and malignant murine tissues. Oncogene 1995, 11:893-898.
55. Vermeesch JR, Price CM: Telomeric DNA sequence and structure following de novo telomere synthesis in Euplotes crassus. Mol Cell Biol 1994, 14:554-566. Exploiting the well defined timing of macronuclear development in Euplotes crassus, the structure of nascent telomeres was examined. Initially, telomeres were longer than in mature macronuclei, and the G-rich strand was more heterogeneous in length than the C-rich strand.
56. Vermeesch JR, Williams D, Price CM: Telomere processing in Euplotes. Nucleic Acids Res 1993, 21:5366-5371.
57. Wellinger RJ, Wolf AJ, Zakian VA: Saccharomyces telomeres acquire single-strand TG1-3 tails iate in S phase. Cell 1993, 72:51-60.
58. Garvik B, Carson M, Hartwell L: Single-stranded DNA arising at telomeres in cdc13 mutants may constitute a specific signal for the RAD9 checkpoint. Mol Cell Biol 1995, 15:6128-6138.
59. Kyrion G, Boakye K, Lustig A: C-terminal truncation of RAP1 results in deregulation of telomere size, stability, and function in Saccharomyces cerevisiae. Mol Cell Biol 1992, 12:5159-5173.